Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection

March 12, 2024 updated by: Ahmet Can Topcu, Dr. Lutfi Kirdar Kartal Training and Research Hospital
Acute aortic dissection is rare but potentially life-threatening disease with an incidence of 5-30 cases per million, annually. Therefore prompt diagnosis is crucial. D-dimer values have been shown to be useful in the diagnosis of acute aortic dissection. Fibrinogen levels have been shown to be low, normal or high in individuals with acute aortic dissection. This study aims to investigate whether D-dimer/fibrinogen ratio can be valuable for diagnosis of acute aortic dissection.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

159

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Istanbul, Turkey, 34668
        • Recruiting
        • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
        • Contact:
      • Istanbul, Turkey, 34890
        • Recruiting
        • Kartal Dr. Lutfi Kirdar Training and Research Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults presenting to emergency department with chest pain.

Description

Inclusion Criteria:

  • Diagnosis of acute aortic dissection
  • Diagnosis of acute pulmonary embolism
  • Diagnosis of non-cardiac chest pain

Exclusion Criteria:

  • Any etiology of chest pain other than acute aortic dissection, acute pulmonary embolism, or non-cardiac chest pain
  • Participants who do not give consent for enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Acute aortic dissection
Patients with a diagnosis of acute aortic dissection.
The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)
Acute pulmonary embolism
Patients with a diagnosis of acute pulmonary embolism
The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)
Non-cardiac chest pain
Patients with non-cardiac chest pain
The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acute aortic dissection
Time Frame: 24 hours
Diagnosis of acute aortic dissection confirmed by contrast enhanced computed tomography, magnetic resonance imaging, echocardiography or aortography
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

January 31, 2025

Study Registration Dates

First Submitted

January 30, 2020

First Submitted That Met QC Criteria

January 30, 2020

First Posted (Actual)

January 31, 2020

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Embolism

Clinical Trials on D-dimer/fibrinogen ratio

3
Subscribe